NOBLE ENG GP (08445) completes the issuance of 55.276 million placing shares.
Noble Engineering Group (08445) announced that the conditions of the placing have been fulfilled, and completion took place on September 21, 2026. Pursuant to the terms and conditions of the placing agreement, an aggregate of 55.276 million placing shares have been successfully placed by the placing agent to not less than six placees at the placing price of HK$0.180 per placing share.
NOBLE ENG GP (08445) announced that the conditions of the placing have been fulfilled, and completion took place on September 21, 2026. Pursuant to the terms and conditions of the placing agreement, an aggregate of 55.276 million placing shares have been successfully placed by the placing agent to not fewer than six placees at the placing price of HK$0.180 per placing share.
Related Articles

CU VENTURE INV (08159) proposes a share consolidation on a "20-into-1" basis.

US Stock Market Move | Optical communication stocks rise; Astera Labs (ALAB.US) gains over 7%.

LEADS BIOLABS-B(09887): Vilxin (opamtisumab, PD-L1/41BB bispecific antibody) monotherapy for advanced EP-NEC pivotal registrational Phase IIB study selected as LBA, and three studies granted preferred oral presentation eligibility
CU VENTURE INV (08159) proposes a share consolidation on a "20-into-1" basis.

US Stock Market Move | Optical communication stocks rise; Astera Labs (ALAB.US) gains over 7%.

LEADS BIOLABS-B(09887): Vilxin (opamtisumab, PD-L1/41BB bispecific antibody) monotherapy for advanced EP-NEC pivotal registrational Phase IIB study selected as LBA, and three studies granted preferred oral presentation eligibility

RECOMMEND





